石四藥(02005.HK)附屬獲確定為先進製造業和現代服務業融合發展試點單位
石四藥集團(02005.HK)公布,集團附屬河北廣祥製藥及河北國龍製藥獲河北省工業和信息化廳認定為河北省省級「專精特新」中小企業。跟據有關的管理辦法,經認定的「專精特新」中小企業。
此外,集團全資附屬石家莊四藥被國家發展改革委確定為第二批先進製造業和現代服務業融合發展試點單位,是河北省僅兩家企業之一。河北廣祥製藥獲河北省發展和改革委員會認定為河北省企業技術中心,亦獲河北省科學技術廳確定今年新建「河北省微通道連續製藥技術創新中心」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.